About Overture Life
Overture Life is a Healthcare company based in Palo Alto (United States) founded in 2017 by Jose Horcajadas, Santiago Munne, and Martin Varsavsky. It operates as an embryology diagnosis devices are developed for medical professionals. Overture Life has raised $49.2 million across 4 funding rounds from investors including Khosla Ventures, Overwater Ventures and Google Ventures. Its chief executive is Hans Gangeskar. Its focus areas include Life Sciences, Women Health, In Vitro Diagnostic Tests and Embryo Viability. Its competitors include NuProbe, Good Start Genetics, Ascelia, Auxogyn and FDNA and 3 more; 7 of its 8 listed competitors have raised funding.
Company details
Founded in 2017 and based in Palo Alto, United States, Overture Life operates in the biotechnology sector focused on reproductive medicine. Automated platforms like DaVitri are provided to streamline egg freezing and embryo warming processes, ensuring consistent timing and improved oocyte survival. Additionally, AI-powered metabolomic tests such as mz are offered for non-invasive embryo selection in clinical settings.
- Headquarters Palo Alto, United States
- Founders Jose Horcajadas, Santiago Munne, Martin Varsavsky
- SectorsHealthcare
- Website overture.life
- Social LinkedIn X
- Total Equity Funding$49.2M (USD)
in 4 rounds
- Latest Funding Round$23.05M (USD), Debt – Conventional
Nov 2025
- InvestorsKhosla Ventures
& 6 more
Funding Insights of Overture Life
Overture Life has successfully raised a total of $49.2M across 4 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $23.05 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $49.2M
- Total Rounds 4
- Last Round Debt – Conventional — $23.05M
- First Round $13.6M
(Dec 2018)
- Investors Count 7
All 4 funding rounds of Overture Life with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2025 | $23.05M | Debt – Conventional | – | European Investment Bank | – |
| Apr 2025 | $20.6M | Series C | – | – | |
| May 2021 | $15M | Series B | – | Octopus Ventures | |
| Dec 2018 | $13.6M | Series A | – | – | – |
7 investors in total: 6 institutional and 1 angel.
Investors in Overture Life
Overture Life has secured backing from 7 investors, including venture fund and angel investors. Prominent investors backing the company include Khosla Ventures, Overwater Ventures and Google Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage venture capital investments are provided to innovative founders. | – | overwater.vc | - | |
Corporate backed venture capital fund investing in multiple sectors | – | gv.com | Mountain View, United States | |
Early-stage startups are funded by this venture capital firm. | 2004 | khoslaventures.com | Menlo Park, United States | |
Venture capital investment and support for founders in technology and health sectors. | – | octopusventures.com | - | |
Investments in technology startups are made by Felicis Ventures. | – | felicis.com | Menlo Park, United States | |
Finance and advisory services for infrastructure projects are provided. | – | eib.org | - | |
MB Marc Benioff | - | – | unknown_91391adb614b4a58a | - |
Investor details for Overture Life
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Overture Life
11 people are tracked at Overture Life (8 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Jose Horcajadas | Co-Founder & Chief Scientific Officer | Leadership |
Santiago Munne | Co-Founder & CIO | Leadership |
Martin Varsavsky | Co-Founder & Chairman | Leadership |
Hans Gangeskar | CEO | Leadership |
Matt Combs | Chief Commercial Officer | Leadership |
Lionel Matthys | Chief Product Officer | Leadership |
Nicolas Foncillas | Chief of Staff | Leadership |
Ana Garci | VP ops | Leadership |
Jesús Mejía González | General Counsel | Team |
Javier Guerrero Sánchez | Biomedical Research & Product Development, PhD | Team |
Francisco Gimon | Purchase & Logistics | Team |
Complete people profiles for Overture Life
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Overture Life
3 dated milestones of Overture Life across 8 years, from founding to its latest funding, stage changes and deals.
- Founded Overture Life is founded.
- Funding First funding round of $13.6M.
- Funding Latest funding round, Debt – Conventional, of $23.0M.
Competitors of Overture Life
Overture Life has 8 listed competitors in our database, 7 of them funded. They include NuProbe, Good Start Genetics, Ascelia, Auxogyn and FDNA, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nuprobe.com | 2016 | George Town, Cayman Islands | $61M | – | Sensitive multiplex platforms for QPCR are developed using toehold probes. | |
| goodstartgenetics.com | 2008 | Boston, United States | $32.16M | – | Molecular diagnostics for inherited genetic disease screening are provided. | |
| ascelia.com | 2000 | Malmo, Sweden | $6.92M | – | Developer of orphan drugs for treatment and diagnostics solutions | |
| auxogyn.com | 2008 | Menlo Park, United States | $78.35M | 384 | Diagnostic technologies for IVF embryo viability assessment are developed. | |
| fdna.com | 2010 | Herzliya, Israel | – | – | Neurogenetic solutions for facial dysmorphic feature detection are developed. | |
| pictordx.com | 2005 | Auckland, New Zealand | $11.1M | – | Immunodiagnostic products are developed via multiplexed assays. | |
| twt.com | 1993 | Xiamen, China | $19.3M | – | Molecular diagnostic devices and reagents are developed and marketed. | |
| vigilantbiosciences.com | 2011 | Fort Lauderdale, United States | $29.76M | – | Solutions for early oral cancer detection are developed and provided. |
Detailed competitors of Overture Life
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Overture Life
The website of Overture Life (overture.life) receives about 4K visits a month.
- Monthly visits4K
▼ 2.3% vs previous month
Top companies in Women's Health & Fertility
10 companies that operate in the same segment as Overture Life (Women's Health & Fertility), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Internet first brand offering wearable breast pumps | 2013 | London, England, United Kingdom | USD 157.63 M | – | – | |
Silicone-filled breast and body shaping implants are designed and manufactured. | 2010 | Alajuela, Alajuela, Costa Rica | USD 121 M | USD 211.08 M | 1,020 | |
Immunotherapeutics for cancer and other diseases are developed. | 2008 | Mainz, Rhineland-palatinate, Germany | USD 805.99 M | USD 3.24 B | 6,770 | |
Developer of cell-free DNA testing for oncology, women’s health, and organ health | 2004 | Redwood City, California, United States | USD 152.1 M | USD 2.31 B | 4,430 | |
Therapeutics for women's healthcare are developed and offered. | 1997 | Princeton, New Jersey, United States | USD 123.06 M | USD 19.59 M | – | |
Provider of cell-free cancer liquid biopsy test | 2015 | San Francisco, California, United States | USD 388.62 M | – | 861 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Platform for breast ultrasound imaging | 2010 | Plymouth, Massachusetts, United States | USD 136.54 M | – | – | |
Silicone breast implants are developed for reconstruction and aesthetic surgery. | 2007 | Dublin, Ireland | USD 232.81 M | – | – | |
A minimally invasive ablation system for uterine fibroids is developed. | 2005 | Redwood City, California, United States | USD 282.54 M | – | 92 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Overture Life
Complete news archive for Overture Life
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Overture Life
Overture Life was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Overture Life is headquartered in Palo Alto, United States. It is registered at Palo Alto, California, United States.
Hans Gangeskar is the current CEO of Overture Life.
Overture Life is a funded company, having raised a total of $49.2M across 4 funding rounds to date. The company's 1st funding round was a Series A of $13.6M, raised on Dec 2018.
Founded in 2017 and based in Palo Alto, United States, Overture Life operates in the biotechnology sector focused on reproductive medicine. Automated platforms like DaVitri are provided to streamline egg freezing and embryo warming processes, ensuring consistent timing and improved oocyte survival. Additionally, AI-powered metabolomic tests such as mz are offered for non-invasive embryo selection in clinical settings.
Overture Life has 7 investors. Key investors include Khosla Ventures, Overwater Ventures, Google Ventures, Octopus Ventures, and Felicis Ventures.